By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Intra-Cellular Therapies, Inc. 

3960 Broadway

New York  New York  10032  U.S.A.
Phone: 212-923-3344 Fax: 212-923-3388


SEARCH JOBS


Industry
Biotechnology






Company News
Intra-Cellular Therapies, Inc. Presents The ITI-007 Clinical Development Program At The 15th International Congress On Schizophrenia Research 3/31/2015 11:06:12 AM
Intra-Cellular Therapies, Inc. To Present At The 15th International Congress On Schizophrenia Research 3/25/2015 8:01:38 AM
Intra-Cellular Therapies, Inc. Reports Fourth Quarter And Full-Year 2014 Financial Results And Provides Corporate Update 3/12/2015 7:44:53 AM
Intra-Cellular Therapies, Inc. Announces Closing Of $130 Million Public Offering Including Exercise Of Underwriters' Option To Purchase Additional Shares 3/12/2015 7:24:55 AM
Intra-Cellular Therapies, Inc. Prices $114 Million Public Offering Of Common Stock 3/6/2015 7:41:29 AM
Intra-Cellular Therapies, Inc. Announces Proposed Public Offering Of Common Stock 3/4/2015 8:18:46 AM
Intra-Cellular Therapies, Inc. To Present At The 2015 RBC Capital Markets' Healthcare Conference 2/18/2015 8:10:30 AM
Intra-Cellular Therapies, Inc. To Present At The Leerink Global Healthcare Conference 2/3/2015 7:54:36 AM
Intra-Cellular Therapies, Inc. To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/12/2015 8:51:52 AM
Intra-Cellular Therapies, Inc. Announces Enrollment Of First Patient In Phase 3 Trial Of ITI-007 For The Treatment Of Schizophrenia 11/25/2014 9:49:31 AM
123456
//-->